RSA
River Street Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Sell |
11,273
-59
| -0.5% | -$11K | 0.9% | 28 |
|
|
2025
Q1 | $2.37M | Buy |
11,332
+513
| +5% | +$107K | 1.18% | 22 |
|
|
2024
Q4 | $1.92M | Buy |
10,819
+224
| +2% | +$39.8K | 0.98% | 29 |
|
|
2024
Q3 | $2.09M | Buy |
10,595
+1,179
| +13% | +$233K | 1.14% | 23 |
|
|
2024
Q2 | $1.62M | Buy |
9,416
+1
| +0% | +$172 | 0.99% | 29 |
|
|
2024
Q1 | $1.71M | Buy |
9,415
+24
| +0.3% | +$4.37K | 1.16% | 25 |
|
|
2023
Q4 | $1.46M | Buy |
9,391
+237
| +3% | +$36.7K | 1.16% | 22 |
|
|
2023
Q3 | $1.36M | Buy |
9,154
+236
| +3% | +$35.2K | 1.29% | 20 |
|
|
2023
Q2 | $1.2M | Sell |
8,918
-304
| -3% | -$41K | 1.15% | 22 |
|
|
2023
Q1 | $1.47M | Buy |
9,222
+153
| +2% | +$24.4K | 1.45% | 14 |
|
|
2022
Q4 | $1.47M | Buy |
+9,069
| New | +$1.47M | 1.57% | 12 |
|